Center-Authored Papers

Filters: Author is Kanakry, Christopher G  [Clear All Filters]
B
Buckley SA, Wood BL, Othus M, Hourigan CS, Ustun C, Linden MA, Defor TE, Malagola M, Anthias C, Valkova V et al..  2017.  Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis.. Haematologica. Abstract
K
Kanakry CG, Bolaños-Meade J, Kasamon YL, Zahurak M, Durakovic N, Furlong T, Mielcarek M, Medeot M, Gojo I, Smith DB et al..  2017.  Low immunosuppressive burden after HLA-matched related or unrelated BMT using post-transplantation cyclophosphamide.. Blood. Abstract
Kanakry CG, O'Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, Mielcarek M, Champlin RE, Jones RJ, Thall PF et al..  2014.  Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(31):3497-505. Abstract
Kanakry CG, Bakoyannis G, Perkins SM, McCurdy SR, Vulic A, Warren EH, Daguindau E, Olmsted T, Mumaw C, Towlerton AMH et al..  2017.  Plasma-derived proteomic biomarkers in HLA-haploidentical or HLA-matched bone marrow transplantation using post-transplantation cyclophosphamide.. Haematologica. Abstract
Kanakry CG, Coffey DG, Towlerton AMH, Vulic A, Storer BE, Chou J, Yeung CCS, Gocke CD, Robins HS, O'Donnell PV et al..  2016.  Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.. JCI insight. 1(5) Abstract